Development of monoclonal antibodies to prevent and treat infections from Flaviviruses

This program funds research to develop experimental monoclonal antibodies for preventing and treating emerging or re-emerging viral infections, including rapid production of antibodies that can target new variants. It aims to improve scientific and clinical understanding and provide candidate therapies for use during epidemics or pandemics.

Amount: €9M — €10M
Type: Program

Key facts

Key facts for Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Amount	€9M — €10M — €37.3M shared across the programme
Issuer	Horizon Europe
Who can apply	See eligibility details
Sectors	Climate · HealthTech
Deadline	Closes 17 Feb 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: ec.europa.eu ↗

Source checked 11 hours ago

10 days agoagentImported from the official source

Opportunities with the same funding type or region
European Degree Exploratory Action		Closes 18 Feb 2027
Selection of hosting sites and fellows for EFSA's European Food Risk Assessment Fellowship (EU-FORA) Programme		Closes 24 Feb 2027
Call for proposals for operating grants in 2027 to non-governmental organisations: financial contribution to the functioning of health non-governmental organisations implementing one or more specific objectives of Regulation (EU) 2021/522 (OA-g-26-91 )		Closes 19 Jan 2027